Puma Biotechnology, Inc.: how funds voted at the meeting of 18 Jun 2024
- Ticker
- PBYI
- Meeting
- Season
- year to 30 June 2024
- Filers reporting
- 115
- Ballot items
- 5
115 filers on Form N-PX reported votes at the Puma Biotechnology, Inc. meeting of 18 Jun 2024. The records fall into 5 ballot items. The page lists them in ballot order: items of the company first, then proposals from security holders. Each bar shows how the reporting filers split. It is not the result of the meeting.
This meeting is in the year to 30 June 2024. The latest season on file is the year to 30 June 2026. The page of Puma Biotechnology, Inc. has the latest meeting.
If the reporting person has not received confirmation of the actual number of votes cast prior to filing a report on Form N-PX, the numbers reported may reflect the number of shares instructed to be cast. A reporting person is not required to amend a previously filed Form N-PX report if the reporting person subsequently receives confirmation of the actual number of votes cast.
The words of the SEC. Source: Form N-PX and its instructions, Special Instructions D.5 and D.8, copied on .
The words of this site: the filer writes each filing. The SEC does not say that it checked the votes. A lender does not vote shares that are on loan. A later filing (Form N-PX/A) can replace an earlier filing, and the site uses the latest.
The figures on this page count the filers that report on Form N-PX and the shares they reported. They do not count all votes cast at the meeting.
The page gives records. It gives no investment advice and no advice on how to vote.
Season on this page: year to 30 June 2024. Filings read through . How the figures are made
The ballot
Item 1: Director elections
8 nominees. 90.5% of the reported votes are for. 18 filers withheld from or voted against at least one nominee.
464 vote records from 34 filers. 0 of the 34 filers that marked the item voted against management.
- Positions of 17 fund families
- For 17
Item 2: Advisory vote on executive pay (say-on-pay)
155 vote records from 113 filers. 10 of the 110 filers that marked the item voted against management. 3 filers gave no management mark.
- Positions of 24 fund families
- For 21
- Against 3
- Against management 3
Item 3: Frequency of the say-on-pay vote
One year: 102 filers. Three years: 6 filers. For: 1 filer. : 1 filer. Not applicable: 1 filer. Abstain: 1 filer.
155 vote records from 113 filers. 7 of the 109 filers that marked the item voted against management. 4 filers gave no management mark.
- Positions of 24 fund families
- Split or no vote 24
- Against management 3
Item 4: Audit-related items (auditor ratification)
58 vote records from 34 filers. 2 of the 34 filers that marked the item voted against management.
- Positions of 17 fund families
- For 17
Item 5: COMPENSATION: management items
The company's items in this category are shown together, because filers word and number them differently.
59 vote records from 33 filers. 4 of the 33 filers that marked the item voted against management.
- Positions of 17 fund families
- For 16
- Against 1
- Against management 1
Positions of the fund families
A position is not the vote of each fund. The position of a family is the way most of the shares reported by its filers were voted. Funds of one family can vote in different ways.
KeyForAgainstAbstain or withholdSplit or no voteAgainst management
| Fund family | 2. Say-on-pay | 3. Pay-vote frequency | 4. Auditor |
|---|---|---|---|
| American Century | Against, against management | Split | For |
| BlackRock and iShares | For | Split | For |
| BNY Mellon | Against, against management | Split | No report |
| Charles Schwab | For | Split | For |
| Dimensional | For | Split, against management | For |
| Equitable | For | Split | For |
| Federated Hermes | For | Split | For |
| Fidelity | For | Split | For |
| Franklin Templeton | For | Split | For |
| Goldman Sachs | For | Split | No report |
| Jackson National funds | For | Split, against management | For |
| Janus Henderson | For | Split | No report |
| John Hancock and Manulife | For | Split | For |
| Lincoln Financial | For | Split, against management | For |
| Macquarie and Delaware Funds | For | Split | For |
| Morgan Stanley, Eaton Vance and Calvert | Against, against management | Split | No report |
| Nationwide | For | Split | For |
| Northern Trust and FlexShares | For | Split | No report |
| PGIM and Prudential | For | Split | No report |
| SEI | For | Split | For |
| State Street and SPDR | For | Split | No report |
| Vanguard | For | Split | For |
| Victory Capital | For | Split | For |
| WisdomTree | For | Split | For |
Questions
- How many filers reported votes at the Puma Biotechnology, Inc. meeting?
- 115 Form N-PX filers reported votes at the meeting of 18 Jun 2024. On say-on-pay, 10 of 110 filers that marked the item voted against management (9.1%).
- Is this the result of the meeting?
- No. The page counts the filers that report on Form N-PX, and the shares they reported. Puma Biotechnology, Inc. reports the result of a vote on Form 8-K.
- Why does the page show counts only for director elections?
- A director record names the nominee. This site has no page and no row about a person. For director elections it keeps the number of nominees and the split of votes.
Provenance: SEC EDGAR, Form N-PX and N-PX/A filings that list Puma Biotechnology, Inc. with a meeting date within three days of 18 Jun 2024. A proposal title is the most common wording among filers. Where a wording can name a person, the SEC category is shown. The filers wrote the filings. Filings read through .